Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × darolutamide × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 25 Urogenital Neoplasms 2 Prostatic Neoplasms, Castration-Resistant 2 Neoplasm Metastasis 2 Biochemically Recurrent Prostate Cancer 2 Adenocarcinoma 2 Urogenital Diseases 1 Prostatic Diseases 1 Prostate Adenocarcinoma 1 Non-metastatic Castration-resistant Prostate Cancer 1 Neoplasms by Site 1 Neoplasms 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1 Male Urogenital Diseases 1 High-Risk Localized Prostate Cancer 1 Granulosa cell tumor of the ovary 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Dasatinib 3 nilotinib 2 asciminib 2 ruxolitinib 1 ponatinib 1 pembrolizumab 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Practice Management, Medical 1 Polymerase Chain Reaction 1 Mycophenolic Acid 1 Methotrexate 1 Interviews as Topic 1 Imatinib Mesylate 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Cyclosporine 1 Cyclophosphamide 1 Blood Specimen Collection 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡